PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Return
26.45%
This Quarter Return
+9.99%
1 Year Return
+26.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$69.2B
AUM Growth
+$1.78B
(+2.6%)
Cap. Flow
-$555M
Cap. Flow
% of AUM
-0.8%
Top 10 Holdings %
Top 10 Hldgs %
13.86%
Holding
2,029
New
469
Increased
982
Reduced
499
Closed
51
Top Buys
| 1 |
Equinix
EQIX
|
+$181M |
| 2 |
Moderna
MRNA
|
+$162M |
| 3 |
Exelon
EXC
|
+$124M |
| 4 |
Waters Corp
WAT
|
+$99.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$74.5M |
Top Sells
| 1 |
Extra Space Storage
EXR
|
+$118M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$107M |
| 3 |
A.O. Smith
AOS
|
+$106M |
| 4 |
Enphase Energy
ENPH
|
+$85.4M |
| 5 |
Evergy
EVRG
|
+$85M |
Sector Composition
| 1 | Technology | 24.96% |
| 2 | Healthcare | 17.38% |
| 3 | Industrials | 15.18% |
| 4 | Utilities | 11.78% |
| 5 | Consumer Discretionary | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
iShares Global Infrastructure ETF
IGF
$8.22B
| $8.43M | 0.01% |
+183,900
| New | +$8.43M |
|
627
Amcor
AMCR
$19.2B
| $8.36M | 0.01% |
701,498
-19,052
| -3% | -$227K |
|
628
Thomson Reuters
TRI
$78.2B
| $8.34M | 0.01% |
70,512
+585
| +0.8% | +$69.2K |
|
629
Northern Trust
NTRS
$24.7B
| $8.34M | 0.01% |
94,209
+533
| +0.6% | +$47.2K |
|
630
Vipshop
VIPS
$8.83B
| $8.28M | 0.01% |
607,200
+124,900
| +26% | +$1.7M |
|
631
Camden Property Trust
CPT
$11.8B
| $8.24M | 0.01% |
73,613
-1,263
| -2% | -$141K |
|
|
MTTR
632
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $8.19M | 0.01% |
2,926,610
-318,282
| -10% | -$891K |
|
633
Clorox
CLX
$15.1B
| $8.09M | 0.01% |
57,645
-1,085
| -2% | -$152K |
|
634
Take-Two Interactive
TTWO
$45.1B
| $8.08M | 0.01% |
77,626
-2,337
| -3% | -$243K |
|
635
Boston Properties
BXP
$12.1B
| $8.02M | 0.01% |
118,733
-15,365
| -11% | -$1.04M |
|
636
PPL Corp
PPL
$26.7B
| $8.01M | 0.01% |
274,154
-61,150
| -18% | -$1.79M |
|
637
Li Auto
LI
$24.4B
| $7.94M | 0.01% |
389,098
-159,945
| -29% | -$3.26M |
|
638
Supernus Pharmaceuticals
SUPN
$2.58B
| $7.94M | 0.01% |
222,509
+58,661
| +36% | +$2.09M |
|
639
Molina Healthcare
MOH
$10.1B
| $7.93M | 0.01% |
24,024
-514
| -2% | -$170K |
|
640
FibroGen
FGEN
$49.8M
| $7.93M | 0.01% |
19,794
+5,225
| +36% | +$2.09M |
|
641
West Pharmaceutical
WST
$18.8B
| $7.9M | 0.01% |
33,571
-1,985
| -6% | -$467K |
|
642
Neogen
NEOG
$1.22B
| $7.88M | 0.01% |
517,662
+107,116
| +26% | +$1.63M |
|
643
Halozyme
HALO
$9.05B
| $7.84M | 0.01% |
137,756
+37,589
| +38% | +$2.14M |
|
644
Live Nation Entertainment
LYV
$40.4B
| $7.72M | 0.01% |
110,735
+40,922
| +59% | +$2.85M |
|
645
On Holding
ONON
$14B
| $7.62M | 0.01% |
443,905
+18,248
| +4% | +$313K |
|
646
EPAM Systems
EPAM
$8.73B
| $7.62M | 0.01% |
23,234
-225
| -1% | -$73.7K |
|
|
BLUE
647
DELISTED
bluebird bio
BLUE
| $7.55M | 0.01% |
54,553
+13,699
| +34% | +$1.9M |
|
648
KeyCorp
KEY
$20.9B
| $7.5M | 0.01% |
430,399
-7,435
| -2% | -$130K |
|
649
Factset
FDS
$13.9B
| $7.49M | 0.01% |
18,667
+698
| +4% | +$280K |
|
650
Agios Pharmaceuticals
AGIO
$2.1B
| $7.46M | 0.01% |
265,718
+70,497
| +36% | +$1.98M |
|